General Information of Drug Off-Target (DOT) (ID: OT8BP6UD)

DOT Name Colorectal cancer-associated protein 1 (COLCA1)
Gene Name COLCA1
Related Disease
Colon cancer ( )
Colon carcinoma ( )
Colorectal adenocarcinoma ( )
Colorectal cancer ( )
Colorectal cancer, susceptibility to, 1 ( )
Colorectal cancer, susceptibility to, 10 ( )
Colorectal cancer, susceptibility to, 12 ( )
Colorectal carcinoma ( )
Colorectal neoplasm ( )
Nasopharyngeal carcinoma ( )
Neoplasm ( )
UniProt ID
COLC1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MESCSVAQAGVLTSPFMWRWTGMAGALSALDNTIEDDADDQLPCGEGRPGWVRGELLGSQ
GVCKDSKDLFVPTSSSLYGCFCVGLVSGMAISVLLLASDFRKLDFSRPEPCFEKEASLWF
VAQH
Tissue Specificity
Expressed in gastrointestinal and immune tissue, as well as prostate, testis and ovary. Expressed in lamina propria and eosinophils but not in epithelial cells. Expression is greater in benign adjacent tissues than in colon tumors.

Molecular Interaction Atlas (MIA) of This DOT

11 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Colon cancer DISVC52G Strong Genetic Variation [1]
Colon carcinoma DISJYKUO Strong Altered Expression [2]
Colorectal adenocarcinoma DISPQOUB Strong Genetic Variation [1]
Colorectal cancer DISNH7P9 Strong Genetic Variation [1]
Colorectal cancer, susceptibility to, 1 DISZ794C Strong Genetic Variation [1]
Colorectal cancer, susceptibility to, 10 DISQXMYM Strong Genetic Variation [1]
Colorectal cancer, susceptibility to, 12 DIS4FXJX Strong Genetic Variation [1]
Colorectal carcinoma DIS5PYL0 Strong Genetic Variation [1]
Colorectal neoplasm DISR1UCN Strong Genetic Variation [1]
Nasopharyngeal carcinoma DISAOTQ0 Strong Genetic Variation [3]
Neoplasm DISZKGEW Strong Genetic Variation [4]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Colorectal cancer-associated protein 1 (COLCA1). [5]
Fulvestrant DM0YZC6 Approved Fulvestrant decreases the methylation of Colorectal cancer-associated protein 1 (COLCA1). [8]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Colorectal cancer-associated protein 1 (COLCA1). [9]
------------------------------------------------------------------------------------
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Colorectal cancer-associated protein 1 (COLCA1). [6]
Tretinoin DM49DUI Approved Tretinoin increases the expression of Colorectal cancer-associated protein 1 (COLCA1). [7]
Formaldehyde DM7Q6M0 Investigative Formaldehyde increases the expression of Colorectal cancer-associated protein 1 (COLCA1). [10]
------------------------------------------------------------------------------------

References

1 Novel Common Genetic Susceptibility Loci for Colorectal Cancer.J Natl Cancer Inst. 2019 Feb 1;111(2):146-157. doi: 10.1093/jnci/djy099.
2 Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer-associated variants.Int J Cancer. 2014 May 15;134(10):2330-41. doi: 10.1002/ijc.28557. Epub 2013 Nov 13.
3 A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.Nat Genet. 2010 Jul;42(7):599-603. doi: 10.1038/ng.601. Epub 2010 May 30.
4 In silico pathway analysis and tissue specific cis-eQTL for colorectal cancer GWAS risk variants.BMC Genomics. 2017 May 15;18(1):381. doi: 10.1186/s12864-017-3750-2.
5 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
6 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
7 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
8 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
10 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.